CAS 66280-26-0: Pregomisin

Pregomisin shows platelet-activating factor (PAF) antagonistic activity and the IC 50 value is 4.8x10(-5) M.

Pregomisin is an investigational compound, which is derived through a synthetic chemical process, with potential applications in therapeutic settings. As a product under investigation, it operates by modulating specific cellular pathways associated with inflammation and immune response. Pregomisin primarily targets molecular mechanisms involving cytokine signaling, thereby influencing cellular behavior in disease conditions. The uses and applications of Pregomisin are primarily focused on its role in experimental models of autoimmune diseases and chronic inflammatory disorders. By acting on these pathways, it offers a potential avenue for understanding disease modulation and therapeutic exploration. Ongoing studies are examining its efficacy and bioavailability in preclinical models, focusing on its pharmacokinetics and safety profile. The ultimate goal is to determine its viability as a candidate for further clinical development, contributing to the expanding landscape of novel therapeutic agents in immunology and inflammation.